ΔΎΉΟΦ±²₯

Meeting Coverage

Psych Congress

Psychiatry & Behavioral Health Learning Network

Psych Congress Roundup: Digital Tx for MDD; Esketamine Rooms; PA Contributions

Studies presented at this year's Psych Congress meeting

Psych Congress over a photo of Boston Convention & Exhibition Center in Boston, MA.

Latest Psych Congress Meeting Coverage

Long-Term Data Support Efficacy, Safety of New Schizophrenia Drug

Nearly 70% of participants had at least a 30% reduction in PANSS total score by week 52

November 6, 2024
Esketamine Also Effective Without Adjunctive Antidepressant

Trial data may expand use, with "opportunity to truly individualize treatment"

November 4, 2024
Adjunctive Antipsychotic Helps Ease Symptoms of Depression

Lumateperone is already FDA approved for schizophrenia and bipolar disorder

November 3, 2024
Stable Schizophrenia Not Necessarily Protective Against Relapse-Related Mortality

Database study shows estimated 5-year survival of 78% even after one relapse episode

November 3, 2024
Novel Drug Improves Depression, Insomnia Symptoms as Add-On Therapy

No approved agent has the same mechanism of action as seltorexant

November 1, 2024
PCPs Often First Stop for Managing Newly Diagnosed Depression

First-year care trajectories looked different than those seeing psychiatrists

September 12, 2023
Safety Profile Sways Physicians on Use of LAIs for Schizophrenia

Nearly half of hesitant prescribers cited safety and tolerability as their top concern

September 12, 2023
Patients With Narcolepsy Face Mood and Pain Disorders

Comorbidities may complicate treatment and diagnosis

September 11, 2023
Long-Acting Schizophrenia Tx Shows Long-Term Safety With Limited Relapses

Most patients on twice-a-year doses of paliperidone palmitate remained relapse-free over 3 years

September 11, 2023
Heart Risks Much Higher for Patients With Rare Sleep Disorder

Treatment should be prescribed with cardiovascular risks in mind, says researcher

September 11, 2023
Spravato Safety Holds Up Long-Term for Treatment-Resistant Depression

Most adverse events dissipated after second or third treatment with intranasal esketamine

September 11, 2023
Physician Assistants Also Feel Post-Pandemic Burnout

Symptoms had some PAs saying they intended to leave their clinical posts sooner rather than later

September 11, 2023
Delayed-Release ADHD Therapy Slightly Mitigates Slowed Growth in Kids

Youth on Jornay PM saw significantly higher weight trajectories

September 9, 2023
How Durable Are Responses to Novel Antidepressant Zuranolone in MDD?

SHORELINE trial found reduced depression symptoms even in those exiting study early

September 23, 2022